|
RNF41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.59639999999639E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.800100E-04 |
| Normal-vs-Stage2 |
5.637100E-03 |
| Normal-vs-Stage3 |
8.39980000000295E-07 |
| Normal-vs-Stage4 |
5.21519999963083E-07 |
| Stage1-vs-Stage2 |
8.828600E-01 |
| Stage1-vs-Stage3 |
3.097800E-02 |
| Stage1-vs-Stage4 |
1.279850E-02 |
| Stage2-vs-Stage3 |
1.866600E-01 |
| Stage2-vs-Stage4 |
1.111590E-01 |
| Stage3-vs-Stage4 |
6.297200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.982420E-04 |
| Normal-vs-AfricanAmerican |
2.985800E-02 |
| Normal-vs-Asian |
1.536030E-03 |
| Caucasian-vs-AfricanAmerican |
6.314400E-01 |
| Caucasian-vs-Asian |
9.391400E-01 |
| AfricanAmerican-vs-Asian |
6.716400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20050000051997E-07 |
| Normal-vs-Female |
1.046570E-04 |
| Male-vs-Female |
2.432200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.918730E-03 |
| Normal-vs-Age(41-60Yrs) |
9.72580000000445E-05 |
| Normal-vs-Age(61-80Yrs) |
1.28760000439598E-08 |
| Normal-vs-Age(81-100Yrs) |
1.381610E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.525000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.301600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.885600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.576200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.381600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.731000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.853500E-02 |
| Classical-VS-Follicular |
2.180400E-01 |
| Classical-VS-Other |
1.745210E-01 |
| Classical-VS-Normal |
4.388100E-04 |
| Tall-VS-Follicular |
4.115600E-01 |
| Tall-VS-Other |
7.408800E-01 |
| Tall-VS-Normal |
3.56879999999782E-05 |
| Follicular-VS-Other |
6.025600E-01 |
| Follicular-VS-Normal |
5.611200E-04 |
| Other-VS-Normal |
8.841200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80628999999488E-05 |
| Normal-vs-N1 |
2.30679999999595E-05 |
| N0-vs-N1 |
2.642400E-01 |
|
|
